{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:26:26Z","timestamp":1795209986556,"version":"4.10.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Precision Medical Research of National Key Research and Development Program","award":["2016YFC0905100"],"award-info":[{"award-number":["2016YFC0905100"]}]},{"name":"Precision Medical Research of National Key Research and Development Program","award":["2016YFC0905100"],"award-info":[{"award-number":["2016YFC0905100"]}]},{"DOI":"10.13039\/501100008410","name":"Shanghai Municipal Population and Family Planning Commission","doi-asserted-by":"publisher","award":["20184Y0073"],"award-info":[{"award-number":["20184Y0073"]}],"id":[{"id":"10.13039\/501100008410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008410","name":"Shanghai Municipal Population and Family Planning Commission","doi-asserted-by":"publisher","award":["201940226"],"award-info":[{"award-number":["201940226"]}],"id":[{"id":"10.13039\/501100008410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p><jats:italic>PYGL<\/jats:italic> mutations can cause liver phosphorylase deficiency, resulting in a glycogenolysis disorder, namely, glycogen storage disease (GSD) VI. The disease is rarely reported in the Chinese population. GSD VI is mainly characterized in untreated children by hepatomegaly, growth retardation and elevated liver transaminases.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>In this study, we report two GSD VI patients with growth retardation and abnormal liver function. There was no obvious hepatomegaly for one of them. Whole exome sequencing (WES) combined with copy number variation analysis was performed. We found a novel homozygous gross deletion, c.1621-258_2178-23del, including exons 14\u201317 of <jats:italic>PYGL<\/jats:italic> in patient 1. The exons 14\u201317 deletion of <jats:italic>PYGL<\/jats:italic> resulted in an in-frame deletion of 186 amino acids. Compound heterozygous mutations of <jats:italic>PYGL<\/jats:italic> were identified in patient 2, including a novel missense mutation c.1832C\u2009&gt;\u2009T\/p.A611V and a recurrent nonsense mutation c.280C\u2009&gt;\u2009T\/p.R94X. After treatment with uncooked cornstarch (UCS) 8\u2009months for patient 1 and 13\u2009months for patient 2, the liver transaminases of both patients decreased to a normal range and their stature was improved. However, patient 1 still showed mild hypertriglyceridemia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We describe two GSD VI patients and expand the spectrum of <jats:italic>PYGL<\/jats:italic> mutations. Patient 1 in this study is the first GSD VI case that showed increased transaminases without obvious hepatomegaly due to a novel homozygous gross deletion of <jats:italic>PYGL<\/jats:italic> identified through WES.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12881-020-01010-4","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T10:03:01Z","timestamp":1586340181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel PYGL mutations in Chinese children leading to glycogen storage disease type VI: two case reports"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiaomei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueren","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"issue":"2","key":"1010_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1566524024605761","volume":"2","author":"PJ Roach","year":"2002","unstructured":"Roach PJ. Glycogen and its metabolism. Curr Mol Med. 2002;2(2):101\u201320.","journal-title":"Curr Mol Med"},{"issue":"18","key":"1010_CR2","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3748\/wjg.v13.i18.2541","volume":"13","author":"H Ozen","year":"2007","unstructured":"Ozen H. Glycogen storage diseases: new perspectives. World J Gastroenterol. 2007;13(18):2541\u201353.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1010_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1086\/301790","volume":"62","author":"B Burwinkel","year":"1998","unstructured":"Burwinkel B, Bakker HD, Herschkovitz E, Moses SW, Shin YS, Kilimann MW. Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet. 1998;62(4):785\u201391.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1010_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"4","key":"1010_CR5","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41436-018-0364-2","volume":"21","author":"PS Kishnani","year":"2019","unstructured":"Kishnani PS, Goldstein J, Austin SL, Arn P, Bachrach B, Bali DS, et al. Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019;21(4):772\u201389.","journal-title":"Genet Med"},{"issue":"4","key":"1010_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/MCO.0000000000000181","volume":"18","author":"P Burda","year":"2015","unstructured":"Burda P, Hochuli M. Hepatic glycogen storage disorders: what have we learned in recent years? Curr Opin Clin Nutr Metab Care. 2015;18(4):415\u201321.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"2","key":"1010_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/gim.2012.104","volume":"15","author":"J Wang","year":"2013","unstructured":"Wang J, Cui H, Lee NC, Hwu WL, Chien YH, Craigen WJ, et al. Clinical application of massively parallel sequencing in the molecular diagnosis of glycogen storage diseases of genetically heterogeneous origin. Genet Med. 2013;15(2):106\u201314.","journal-title":"Genet Med"},{"issue":"5","key":"1010_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s10545-007-0499-9","volume":"30","author":"NJ Beauchamp","year":"2007","unstructured":"Beauchamp NJ, Taybert J, Champion MP, Layet V, Heinz-Erian P, Dalton A, et al. High frequency of missense mutations in glycogen storage disease type VI. J Inherit Metab Dis. 2007;30(5):722\u201334.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1010_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/hmg\/7.5.865","volume":"7","author":"S Chang","year":"1998","unstructured":"Chang S, Rosenberg MJ, Morton H, Francomano CA, Biesecker LG. Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Hum Mol Genet. 1998;7(5):865\u201370.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1010_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00431-019-03499-1","volume":"179","author":"TR Aeppli","year":"2020","unstructured":"Aeppli TR, Rymen D, Allegri G, Bode PK, H\u00e4berle J. Glycogen storage disease type VI: clinical course and molecular background. Eur J Pediatr. 2020;179(3):405\u201313.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1010_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2014.09.005","volume":"113","author":"A Roscher","year":"2014","unstructured":"Roscher A, Patel J, Hewson S, Nagy L, Feigenbaum A, Kronick J, et al. The natural history of glycogen storage disease types VI and IX: long-term outcome from the largest metabolic center in Canada. Mol Genet Metab. 2014;113(3):171\u20136.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1010_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S1096-7192(03)00068-4","volume":"79","author":"NL Tang","year":"2003","unstructured":"Tang NL, Hui J, Young E, Worthington V, To KF, Cheung KL, et al. A novel mutation (G233D) in the glycogen phosphorylase gene in a patient with hepatic glycogen storage disease and residual enzyme activity. Mol Genet Metab. 2003;79(2):142\u20135.","journal-title":"Mol Genet Metab"},{"issue":"11","key":"1010_CR13","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, et al. Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum Mutat. 2018;39(11):1517\u201324.","journal-title":"Hum Mutat"},{"issue":"11","key":"1010_CR14","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1016\/j.ymthe.2017.07.014","volume":"25","author":"Y Echigoya","year":"2017","unstructured":"Echigoya Y, Lim KRQ, Trieu N, Bao B, Miskew Nichols B, Vila MC, et al. Quantitative antisense screening and optimization for exon 51 skipping in Duchenne muscular dystrophy. Mol Ther. 2017;25(11):2561\u201372.","journal-title":"Mol Ther"},{"issue":"11","key":"1010_CR15","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/hep4.1426","volume":"3","author":"LH Wilson","year":"2019","unstructured":"Wilson LH, Cho J-H, Estrella A, Smyth JA, Wu R, Chengsupanimit T, et al. Liver glycogen phosphorylase deficiency leads to profibrogenic phenotype in a murine model of glycogen storage disease type VI. Hepatol Commun. 2019;3(11):1544\u201355.","journal-title":"Hepatol Commun"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-020-01010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-020-01010-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-020-01010-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T23:19:47Z","timestamp":1617837587000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-020-01010-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1010"],"URL":"https:\/\/doi.org\/10.1186\/s12881-020-01010-4","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]},"assertion":[{"value":"30 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Xinhua Hospital Ethics Committee Affiliated to Shanghai Jiao tong University School of Medicine (XHEC-D-2019-057). The control samples in Fig. a and e were from volunteers. Written informed consent was obtained from parents of the patients and the controls.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical details was obtained from the parents of participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}